ams AG selects Extra Horizon to power innovative point-of-care cloud solution for its lab-quality, spectral sensor-enhanced lateral flow test solution to help fight COVID-19
- ams and Extra Horizon team to fight the pandemic by creating a medical-cloud connected spectral sensor-based solution for Lateral Flow Test (LFT)
- ams provides an easy-to-use, lab-free Covid-19 (SARS-CoV-2) antigen or antibody test read-out solution which provides highly reliable results in around 15 minutes at the point-of-care
- Extra Horizon provides its world leading, high-performance, medical-grade cloud solution for almost instant results to your smartphone
- The proven capabilities of Extra Horizon’s global platform ensures test results can be processed over a wide geographical reach securely, reliably, in real time – up to millions at a time –, all the while ensuring full compliance with local data processing regulations, including GDPR for handling sensitive data
- A full production line for ams spectral sensor-based SARS-CoV-2 antibody digital rapid tests has already been inaugurated with Germany-based Senova
An extra weapon in the fight against COVID-19
The COVID-19 pandemic has underlined the importance of highly accurate and secure rapid testing and instant data availability, particularly when that data is critical to developing and managing lockdown strategies. The combination of the ams spectral sensor and Extra Horizon’s connected solution pave the way for a range of digital point-of-care tests, including extremely fast and highly accurate lateral flow (immuno assay) tests.
The proven capabilities of Extra Horizon’s global platform ensure a wide geographical reach. This means the results of those tests can be processed securely, reliably and in real time, up to millions at a time – all the while ensuring full compliance with local data processing regulations, including GDPR for handling sensitive data.
Pierre Laboisse, Executive Vice President Global Sales and Marketing, ams AG:
“Governments and authorities need to enable fast, reliable and effective testing with the results available through a fast, secure and GDPR-compliant medical-grade cloud solution.”
Driving the digital transition of IVD technologies
Lars Grieten, CEO, Extra Horizon:
“This global partnership is a powerful demonstration of how state-of-the-art health tech sensors can be enhanced with digital infrastructure to deliver point-of-care testing solutions both in the professional and home environment.”
An easy replicable formula
The software component of the point-of-care sensor solution is powered by Extra Horizon’s robust and fully compliant backend solution. The platform relieves the burden of regulatory compliance and reduces investment risk, providing companies with the technical framework and complementary services they need to build sophisticated medical applications with greater speed, flexibility, scalability, and reliability.